Please login to the form below

Not currently logged in
Email:
Password:

Global Pricing Innovations

This page shows the latest Global Pricing Innovations news and features for those working in and with pharma, biotech and healthcare.

Global Pricing Innovations and Partners4Access partner on market access

Global Pricing Innovations and Partners4Access partner on market access

Will collaborate on orphan drug pricing and access solutions. Global Pricing Innovations and Partners4Access have formed a strategic partnership to offer pricing and access solutions for orphan drugs. ... Founder and chief executive of Global Pricing

Latest news

More from news
Approximately 1 fully matching, plus 0 partially matching documents found.

Latest appointments

  • GPI appoints commercial director GPI appoints commercial director

    Alan Stewart joins the life science management consultancy's executive team. London, UK-based Global Pricing Innovations has strengthened its executive team with the appointment of Alan Stewart as commercial director. ... Stewart joins the pharmaceutical

More from appointments
Approximately 1 fully matching, plus 0 partially matching documents found.

Latest from PMHub

  • Global Pricing Innovations Ltd (GPI)

    Global Pricing Innovations supports price decision-making through data-driven insights and bespoke analytical solutions. ... Global Pricing Innovations Ltd (GPI).

More from PMHub
Approximately 0 fully matching, plus 1 partially matching documents found.

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Life Healthcare Communications

Life is a creative communications agency offering multi-channel solutions for the healthcare industry. We use a storytelling approach to turn...

Latest intelligence

Virtual meeting technologies for reducing emissions and waste in the healthcare industry
...
Diversity in clinical trials: looking back at our 2021 blogs
In this blog, we look back at the Innovative Trials' Equality & Diversity (E&D) committee blogs across 2021...
What does the future hold for Light-chain Amyloidosis?
Recent advances in the understanding and treatment are reforming pharma’s approach to the management of this rare disease. With a new standard of care rapidly developing, what does the landscape...